Wiley.com
Journal

Epilepsia

More Press Releases related to this journal
Edited By: Astrid Nehlig, PhD and Michael Sperling, MD
Print ISSN: 0013-9580 Online ISSN: 1528-1167
Impact Factor: 5.067

More Press Releases in:

Medicine & Healthcare, Wiley-Blackwell


Full citation: “Prevention of Bone Loss and Vertebral Fractures in Patients with Chronic Epilepsy—Antiepileptic Drug and Osteoporosis Prevention Trial.” Antonio A. Lazzari, Philip M. Dussault, Manisha Thakore-James, David Gagnon, Errol Baker, Samuel A. Davis and Antoun M. Houranieh. Epilepsia; Print Publication: November 6, 2013 (DOI: 10.1111/epi.12351).

URL: http://doi.wiley.com/10.1111/epi.12351

About the Journal
Epilepsia is the leading, most authoritative source for current clinical and research results on all aspects of epilepsy. As the journal of the International League Against Epilepsy, subscribers every month will review scientific evidence and clinical methodology in: clinical neurology, neurophysiology, molecular biology, neuroimaging, neurochemistry, neurosurgery, pharmacology, neuroepidemiology, and therapeutic trials. For more information, please visit http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1528-1167.


About the International League Against Epilepsy
The International League Against Epilepsy (ILAE) is the world’s preeminent association of physicians and health professionals working toward a world where no person’s life is limited by epilepsy. Since 1909 the ILAE has provided educational and research resources that are essential in understanding, diagnosing and treating persons with epilepsy. The ILAE supports health professionals, patients, and their care providers, governments, and the general public worldwide by advancing knowledge of epilepsy.

Learn more about this journal on Wiley Online Library